Vice President, Platform and Process Sciences

Dr. Gang Yin is an accomplished scientist and experienced R&D team leader with over 18 years of expertise in research and drug development. After earning his Ph.D. from Tsinghua University, he started working on the development and application of Cell-free protein synthesis in the lab of Prof. Jim Swartz at Stanford University. In 2004, Dr. Yin joined Sutro Biopharma where he has held various positions and is currently leading the Platform Engineering and Process Research Department.

With a proven track record of success as a project leader on multiple programs, Dr. Yin has contributed to the progression of several programs into clinical trials. Notably, the collaboration with Merck led to the discovery of MK-1484. Dr. Yin is an expert in ADC and cytokine biologics development strategies, with a particular emphasis on strain engineering, antibody discovery, expression, purification, conjugation, and drug lead characterization. He is the pioneer of site-specific ADC development through non-natural amino acid incorporation.

Dr. Yin’s strategic and scientific leadership skills, coupled with his expertise in protein biochemistry, have significantly contributed to the success of the company. He has authored 30+ publications and holds 10+ patents.